JPWO2022255349A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022255349A5 JPWO2022255349A5 JP2023525850A JP2023525850A JPWO2022255349A5 JP WO2022255349 A5 JPWO2022255349 A5 JP WO2022255349A5 JP 2023525850 A JP2023525850 A JP 2023525850A JP 2023525850 A JP2023525850 A JP 2023525850A JP WO2022255349 A5 JPWO2022255349 A5 JP WO2022255349A5
- Authority
- JP
- Japan
- Prior art keywords
- concentration
- hemorrhagic stroke
- soluble
- clec2
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000016988 Hemorrhagic Stroke Diseases 0.000 claims description 31
- 208000020658 intracerebral hemorrhage Diseases 0.000 claims description 31
- 102100032529 C-type lectin domain family 1 member B Human genes 0.000 claims description 24
- 101000942284 Homo sapiens C-type lectin domain family 1 member B Proteins 0.000 claims description 24
- 238000000034 method Methods 0.000 claims description 19
- 238000012502 risk assessment Methods 0.000 claims description 6
- 210000004369 blood Anatomy 0.000 claims description 4
- 239000008280 blood Substances 0.000 claims description 4
- 210000001772 blood platelet Anatomy 0.000 description 18
- 239000000243 solution Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000003018 immunoassay Methods 0.000 description 3
- 230000010118 platelet activation Effects 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
- 239000007995 HEPES buffer Substances 0.000 description 2
- 239000007987 MES buffer Substances 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 229940126619 mouse monoclonal antibody Drugs 0.000 description 2
- HEGSGKPQLMEBJL-RKQHYHRCSA-N octyl beta-D-glucopyranoside Chemical compound CCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HEGSGKPQLMEBJL-RKQHYHRCSA-N 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- BYKRNSHANADUFY-UHFFFAOYSA-M sodium octanoate Chemical compound [Na+].CCCCCCCC([O-])=O BYKRNSHANADUFY-UHFFFAOYSA-M 0.000 description 2
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 1
- 208000032851 Subarachnoid Hemorrhage Diseases 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- UKWLRLAKGMZXJC-QIECWBMSSA-L disodium;[4-chloro-3-[(3r,5s)-1-chloro-3'-methoxyspiro[adamantane-4,4'-dioxetane]-3'-yl]phenyl] phosphate Chemical compound [Na+].[Na+].O1OC2([C@@H]3CC4C[C@H]2CC(Cl)(C4)C3)C1(OC)C1=CC(OP([O-])([O-])=O)=CC=C1Cl UKWLRLAKGMZXJC-QIECWBMSSA-L 0.000 description 1
- 238000011984 electrochemiluminescence immunoassay Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021091607 | 2021-05-31 | ||
| PCT/JP2022/022077 WO2022255349A1 (ja) | 2021-05-31 | 2022-05-31 | 可溶型ｃｌｅｃ２を用いた出血性脳卒中のリスク評価法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2022255349A1 JPWO2022255349A1 (https=) | 2022-12-08 |
| JPWO2022255349A5 true JPWO2022255349A5 (https=) | 2025-03-21 |
Family
ID=84323410
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023525850A Pending JPWO2022255349A1 (https=) | 2021-05-31 | 2022-05-31 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240264175A1 (https=) |
| EP (1) | EP4350350A4 (https=) |
| JP (1) | JPWO2022255349A1 (https=) |
| KR (1) | KR20240017001A (https=) |
| CN (1) | CN117769652A (https=) |
| WO (1) | WO2022255349A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025075139A1 (ja) * | 2023-10-06 | 2025-04-10 | Ｐｈｃ株式会社 | 可溶型ｃｌｅｃ－２を用いた脳心血管・腎イベントの長期的発症ハイリスク評価法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6078845U (ja) | 1983-11-04 | 1985-06-01 | ライオン株式会社 | 食用廃油固化処理用具 |
| AU2002359815A1 (en) * | 2001-12-19 | 2003-07-09 | Immunex Corporation | C-type lectin polypeptide, polynucleotide and methods of making and use thereof |
| JP6078845B2 (ja) * | 2012-09-28 | 2017-02-15 | 株式会社Ｌｓｉメディエンス | 可溶型ｃｌｅｃ−２に基づく血小板活性化測定方法 |
| US10227407B2 (en) * | 2013-10-10 | 2019-03-12 | Yukinari Kato | Anti-podoplanin antibody |
| JP7172286B2 (ja) | 2018-08-28 | 2022-11-16 | スズキ株式会社 | ニーエアバッグ取付け構造 |
| JP6883348B2 (ja) | 2019-06-26 | 2021-06-09 | 稔 甲斐 | 閉塞防止機能付振動篩用網及び振動篩装置 |
| EP4113524A4 (en) * | 2020-02-28 | 2024-03-06 | LSI Medience Corporation | METHOD FOR MEASURING PLATELE ACTIVATION BASED ON SOLUBLE CLEC-2 AND PLATELE COUNT |
-
2022
- 2022-05-31 EP EP22816095.8A patent/EP4350350A4/en active Pending
- 2022-05-31 JP JP2023525850A patent/JPWO2022255349A1/ja active Pending
- 2022-05-31 KR KR1020237044828A patent/KR20240017001A/ko active Pending
- 2022-05-31 CN CN202280038986.4A patent/CN117769652A/zh active Pending
- 2022-05-31 WO PCT/JP2022/022077 patent/WO2022255349A1/ja not_active Ceased
- 2022-05-31 US US18/565,258 patent/US20240264175A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ray et al. | Relationship of platelet aggregation to bleeding after cardiopulmonary bypass | |
| JP7648188B2 (ja) | ミスフォールドタンパク質を検出するためのデバイスおよびその使用方法 | |
| JP7546037B2 (ja) | 可溶型ｃｌｅｃ－２と血小板数に基づく血小板活性化測定方法 | |
| JP2012168012A (ja) | 血管内皮障害を検査するための新規な検査方法および検査用キット | |
| CN101460852A (zh) | Mrp8/14水平用于鉴别个体处于急性冠状动脉综合症风险中的应用 | |
| WO2014068018A1 (en) | Methods of prognosis and diagnosis of sepsis | |
| Ohuchi et al. | Association of the plasma platelet-derived microparticles to platelet count ratio with hospital mortality and disseminated intravascular coagulopathy in critically ill patients | |
| JPWO2022255349A5 (https=) | ||
| CN105021827A (zh) | 检测血清血管生成素样蛋白2含量的物质在制备检测肝脏炎症和纤维化程度产品中的应用 | |
| Fernandes et al. | Flow cytometric assessment of feto‐maternal hemorrhage; a comparison with Betke–Kleihauer | |
| JPWO2022255348A5 (https=) | ||
| JP2000193662A (ja) | 尿中シスタチンｃ測定試薬及び診断方法並びにキット | |
| EP4350350A1 (en) | Method for assessing risk of hemorrhagic stroke using soluble clec2 | |
| EP4350349A1 (en) | Method for evaluating risk of acute cerebral vascular disease using soluble clec2 | |
| CN204330776U (zh) | 一种心肌梗塞快速检测胶体金试剂盒 | |
| CN114660285A (zh) | 一种子痫前期测定试剂盒、制备方法及应用 | |
| JP2023513371A (ja) | 虚血貧血および急性呼吸窮迫症候群を治療する装置および方法 | |
| CN113533739A (zh) | 辅助预测呼吸器感染症重症化及监测生物标志物测定值的方法、试剂盒、装置及计算机程序 | |
| CN118853810B (zh) | 用于评估肝病进展程度和预后的分子标志物、诊断试剂盒及其应用 | |
| US20110269150A1 (en) | Compositions and methods for predicting cardiovascular events | |
| CN118130788A (zh) | 血栓调节蛋白免疫层析试纸条、试剂盒及在脓毒症中的应用 | |
| JP2024027767A (ja) | 可溶型ｃｌｅｃ２を用いた血小板減少性疾患の診断法 | |
| WO2025075139A1 (ja) | 可溶型ｃｌｅｃ－２を用いた脳心血管・腎イベントの長期的発症ハイリスク評価法 | |
| HK40106384A (en) | Method for assessing risk of hemorrhagic stroke using soluble clec2 | |
| KR20170122144A (ko) | 타액을 이용한 정보 제공 키트 |